We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Denali Rose, VP at Veeva, and Co-Host of Note to File. Rose’s parents are outdoors people and named her after the national park in Alaska. Personally, this is one of the most fun shows we’ve ever done. ‘Nuff said – get in and listen! She is Vice President Sales & Strategy, Site Solutions at Veeva. That’s her day job – she’s also the Co-Host and Producer of the Note To File podcast. She’s focused on delivering solutions for clinical research sites, guiding the sales cycle, and aligning strategy to drive impact and growth. She’s super smart and extremely experienced in the patterns and anti-patterns in the clinical trial industry.

Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

• Tell me about your journey.
• How did you get into podcasting, and why do you think it’s important?
• CROs are part of the problem, and therefore, they cannot be a part of the solution; sites will inherit the Earth – what is your take on this? Do you think CROs are part of the problem and therefore can’t be part of the solution? Do you think sites will actually inherit the Earth?
• What other hats do you wear besides ClinOps?

Now, without further ado, we’re excited to share with you the next episode of the Life Sciences Today podcast.

Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

• Apple Podcasts
• Spotify
• iHeartRadio
• Amazon Music
• Pandora
• YouTube

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!

We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is David Bates, Founder and CEO at Linus Health. I talk with David Bates about Linus Health’s mission to transform brain health from late-stage “sick care” to proactive, preventive care. David explains his journey from signal detection research and investing in built-environment technologies to founding Linus Health around the insight that behavior is the primary observable output of the brain. We discuss Linus’s 3-minute digital cognitive assessments that turn rich behavioral signals into thousands of digital biomarkers, enabling highly sensitive, objective measurement of cognition and early detection of impairment years before symptoms. Our conversation covers the company’s focus on primary care and health systems as core customers, revenue and ROI in fee-for-service and value-based care, and Linus’s data moat of large, diverse, longitudinal datasets. We explore how clinically integrated, consumer-accessible tools could make brain health monitoring continuous—like a “blood pressure cuff for the brain”—and why this paradigm shift is critical for both healthcare delivery and drug development.

Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

• How did your background in signal detection, multimodal sensing, and investing lead you to found Linus Health?
• What does Linus Health’s platform actually do, and how are your digital assessments different from traditional paper-based cognitive tests?
• Who are your main customers today (primary care, health systems, pharma, payers), and how do you create and capture value across these different buyer types?
• How do you translate thousands of digital biomarkers and AI/ML models into clinically meaningful insights, and how often are your models updated?
• What is your long-term vision? Is the biggest opportunity in supporting drug development, or in becoming a clinically integrated, mass-market “Internet of bodies” brain health platform for consumers?

Now, without further ado, we’re excited to share with you the next episode of the Life Sciences Today podcast.

Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

• Apple Podcasts
• Spotify
• iHeartRadio
• Amazon Music
• Pandora
• YouTube

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!